NICEON also proved successful in controlling multicistronic expression units for coordinated transcription of up to three transgenes and in the fine-tuning of transcription translation networks, in which RNA polymerase II- and III-dependent promoters, engineered for 6HNic responsiveness, drove expression of siRNAs that triggered specific transgene knockdown.
The BAS includes three distinct subscales: reward responsiveness, drive, and fun seeking.
This study investigated whether individual differences in the BAS, namely Reward Responsiveness, Drive, and Fun Seeking, were associated with offers made in two decision-making tasks: the Ultimatum Game and the Dictator Game.
Behavioural Inhibition & Activation: The 24-item self-reported Behavioural Inhibition/Behavioural Activation System (BIS/BAS) Scale [ 42] assessed neuroticism, behavioural inhibition and behavioural activation with subscales for reward responsiveness, drive and fun-seeking.
Specifically, we studied a personality dimension that may influence economic decision-making, the Behavioral Activation System, (BAS) which is composed of three components: Reward Responsiveness, Drive, and Fun Seeking.
Hence, the direction that the immune response is driven – overall responsiveness or tolerance – will depend on when the IL2R is being expressed, on which cells, and whether IL-2 cytokine is present.
In the Dictator Game, when the partner cannot reject the offer, people with higher Reward Responsiveness and Drive now make lower offers, thus maximizing their own gains.
The timing of the antigenic stimulation of the immune system pathways is potentially important, as the direction that the immune system will be driven – responsiveness or tolerance – might reasonably be expected to depend upon the relative effector versus regulatory balance that exists at the time of stimulation.
Importantly, this link between responsiveness and healthy cortisol was driven, at least in part, by diminishing negative emotions over the decade.
However, utilizing these data to provide greater mechanistic insight into the processes that drive therapeutic responsiveness may require a hypothesis driven, 'bottom up' approach that starts with a functional end-point and works toward determining its clinical relevance [ 2].
